Erudio Healtherudio.com
Clinical trial · no report yet · Phase 1
GlutaPanc
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
- NCT04634539 ↗
- Completed
- Jun Gong, MD
- Focused
We haven't built an HCP commentary report on GlutaPanc (l-glutamine, gemcitabine and 1 more in Advanced Pancreatic Adenocarcinoma) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on GlutaPanc so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 5 |
The trial
ClinicalTrials.gov- Official title
- IIT2020-02-Gong-GlutaPanc: Phase I Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (GlutaPanc)
- Phase
- Phase 1
- Status
- Completed
- Conditions
- Advanced Pancreatic Adenocarcinoma; Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma
- Interventions
- Gemcitabine; Nab-paclitaxel; L-glutamine
- Arms
- Gemcitabine + Nab-paclitaxel + L-glutamine · Experimental
- Enrollment
- 18
- Primary outcomes
- Recommended phase II dose (RP2D) of combination gemcitabine, nab-paclitaxel, and L-glutamine in treatment-naive metastatic pancreatic cancer.
- Sponsor
- Jun Gong, MD with Emmaus Medical, Inc.
- Start
- May 13, 2021
- Primary completion
- Jul 6, 2023
- Results posted
- No
- Registry record
- NCT04634539 · updated Aug 6, 2025
Publications
linked from the registry- Gong J, Muranaka H, Choi SY, Tighiouart M, Bhute S, Aja ER, Jacobs JP, Stotland A, Van Eyk J, Elmadbouh OHM, Edderkaoui M, Tanaka S, Furuya H, Osipov A, Lorber J, Billet S, Morris A, Ten Hoeve-Scott J, Graeber T, Pandol SJ, Hendifar A, Bhowmick NA. L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial. Nat Cancer. 2026 Aug 31. doi: 10.1038/s43018-026-01225-z. Online ahead of print. PubMed 42675216